Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010–2011

Claudia C. Dobler, Sarah Korver, Ochirbat Batbayar, Batiargal Nyamdulam, Sodnomdarjaa Oyuntsetseg, Bold Tsolmon, Bazarragchaa Surmaajav, Byambaa Bayarjargal, Ben J. Marais

Research output: Contribution to journalArticleResearchpeer-review

14 Citations (Scopus)

Abstract

In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear–positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquired MDR TB and a need to make rapid molecular drug susceptibility testing available to more people.

Original languageEnglish
Pages (from-to)1451-1454
Number of pages4
JournalEmerging Infectious Diseases
Volume21
Issue number8
DOIs
Publication statusPublished - 23 Jul 2015
Externally publishedYes

Fingerprint

Mongolia
Multidrug-Resistant Tuberculosis
Sputum
Tuberculosis
Therapeutics
Pharmaceutical Preparations

Cite this

Dobler, Claudia C. ; Korver, Sarah ; Batbayar, Ochirbat ; Nyamdulam, Batiargal ; Oyuntsetseg, Sodnomdarjaa ; Tsolmon, Bold ; Surmaajav, Bazarragchaa ; Bayarjargal, Byambaa ; Marais, Ben J. / Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010–2011. In: Emerging Infectious Diseases. 2015 ; Vol. 21, No. 8. pp. 1451-1454.
@article{1b129b5a9502495b8bd4a2c9977d71bb,
title = "Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010–2011",
abstract = "In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear–positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquired MDR TB and a need to make rapid molecular drug susceptibility testing available to more people.",
author = "Dobler, {Claudia C.} and Sarah Korver and Ochirbat Batbayar and Batiargal Nyamdulam and Sodnomdarjaa Oyuntsetseg and Bold Tsolmon and Bazarragchaa Surmaajav and Byambaa Bayarjargal and Marais, {Ben J.}",
year = "2015",
month = "7",
day = "23",
doi = "10.3201/eid2108.141860",
language = "English",
volume = "21",
pages = "1451--1454",
journal = "Emerging Infectious Diseases",
issn = "1080-6040",
publisher = "Centers for Disease Control and Prevention (CDC)",
number = "8",

}

Dobler, CC, Korver, S, Batbayar, O, Nyamdulam, B, Oyuntsetseg, S, Tsolmon, B, Surmaajav, B, Bayarjargal, B & Marais, BJ 2015, 'Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010–2011' Emerging Infectious Diseases, vol. 21, no. 8, pp. 1451-1454. https://doi.org/10.3201/eid2108.141860

Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010–2011. / Dobler, Claudia C.; Korver, Sarah; Batbayar, Ochirbat; Nyamdulam, Batiargal; Oyuntsetseg, Sodnomdarjaa; Tsolmon, Bold; Surmaajav, Bazarragchaa; Bayarjargal, Byambaa; Marais, Ben J.

In: Emerging Infectious Diseases, Vol. 21, No. 8, 23.07.2015, p. 1451-1454.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010–2011

AU - Dobler, Claudia C.

AU - Korver, Sarah

AU - Batbayar, Ochirbat

AU - Nyamdulam, Batiargal

AU - Oyuntsetseg, Sodnomdarjaa

AU - Tsolmon, Bold

AU - Surmaajav, Bazarragchaa

AU - Bayarjargal, Byambaa

AU - Marais, Ben J.

PY - 2015/7/23

Y1 - 2015/7/23

N2 - In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear–positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquired MDR TB and a need to make rapid molecular drug susceptibility testing available to more people.

AB - In Ulaanbaatar, Mongolia, multidrug-resistant tuberculosis (MDR TB) was diagnosed for more than a third of new sputum smear–positive tuberculosis patients for whom treatment had failed. This finding suggests a significant risk for community-acquired MDR TB and a need to make rapid molecular drug susceptibility testing available to more people.

UR - http://www.scopus.com/inward/record.url?scp=84937405758&partnerID=8YFLogxK

U2 - 10.3201/eid2108.141860

DO - 10.3201/eid2108.141860

M3 - Article

VL - 21

SP - 1451

EP - 1454

JO - Emerging Infectious Diseases

JF - Emerging Infectious Diseases

SN - 1080-6040

IS - 8

ER -